Women and Longevity Research: Why Most Longevity Studies Are Done in Male Animals

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

The historical exclusion of female animals in longevity research has created a knowledge gap, hindering the development of sex-specific anti-aging strategies.

The quest for extended healthspan and lifespan is a fundamental pursuit in biomedical science. However, a pervasive and long-standing bias in longevity research has disproportionately focused on male animals, creating a significant knowledge gap regarding female-specific aging processes and responses to anti-aging interventions. This male-centric approach has profound implications for understanding and promoting longevity in women.

The Historical Bias: A Legacy of Convenience and Misconception

The historical preference for male animals in research, particularly in fields like pharmacology, toxicology, and aging, stems from several factors:

  • Hormonal Fluctuations: Female animals, with their estrous or menstrual cycles, exhibit fluctuating hormone levels (e.g., estrogen, progesterone). Researchers often perceived these fluctuations as a source of variability that could complicate experimental results and statistical analysis, making studies more expensive and time-consuming [1].
  • Cost and Logistics: Maintaining separate housing and experimental protocols for male and female animals, and accounting for reproductive cycles, adds to the complexity and cost of research.
  • Historical Precedent: Early research often established male-only cohorts, and this practice became entrenched, perpetuating the bias through inertia.
  • Misconception of 'Universal' Biology: A prevailing, yet flawed, assumption was that findings from male animals could be universally applied to both sexes, overlooking fundamental biological differences.

    • The Consequences: A Skewed Understanding of Aging

    The exclusion of female animals has led to a skewed and incomplete understanding of the aging process:

    Sex-Specific Aging Mechanisms: Men and women age differently at cellular, molecular, and physiological levels. For example, hormonal changes during menopause profoundly impact women's cardiovascular, bone, and cognitive health in ways that have no direct male equivalent. Research primarily in males misses these critical female-specific aging pathways [2].

    Differential Responses to Interventions: Anti-aging interventions (e.g., caloric restriction, rapamycin, metformin) often show sex-specific effects on lifespan and healthspan. What works for males may not work, or may even be detrimental, for females. For instance, some interventions that extend male lifespan have no effect or even shorten female lifespan [3].

    Drug Development Gaps: A lack of female-specific data means that drugs and therapies developed based on male-dominated research may be less effective, or have different side effect profiles, in women. This contributes to health disparities and suboptimal outcomes for women.

    Underestimation of Female Healthspan: By not fully understanding female aging, we may be underestimating the potential for extending women's healthy years and failing to develop targeted strategies to address female-predominant age-related diseases like Alzheimer's disease and osteoporosis.

    The Shift Towards Inclusivity: Policy and Scientific Imperatives

    Recognizing these critical shortcomings, major funding bodies and scientific journals have begun to mandate the inclusion of both sexes in preclinical research. For example, the National Institutes of Health (NIH) in the United States implemented a policy in 2016 requiring researchers to consider sex as a biological variable in their study designs [4].

    This shift is driven by a scientific imperative to achieve a more accurate and comprehensive understanding of biology. Including female animals allows researchers to:

    Identify Sex-Specific Biomarkers: Discover biomarkers of aging and disease that are unique to or more pronounced in females.

    Develop Tailored Interventions: Design anti-aging strategies and therapies that are optimized for female physiology.

    Uncover Novel Mechanisms: Reveal fundamental biological mechanisms of aging that might be masked or absent in male-only studies.

    Conclusion

    The historical bias towards male animals in longevity research has created a significant void in our understanding of female aging. While the complexities of female biology, particularly hormonal cyclicity, presented experimental challenges, the scientific community is increasingly recognizing that ignoring sex as a biological variable is no longer tenable. Moving forward, a concerted effort to include both sexes in all stages of longevity research is paramount. This inclusive approach will not only lead to more robust and generalizable scientific findings but, more importantly, will pave the way for the development of truly effective and personalized anti-aging interventions that can optimize healthspan and extend healthy life for all individuals, regardless of sex.

    References

    [1] Clayton, J. A., & Collins, F. S. (2014). Policy: NIH to balance sex in cell and animal studies. Nature, 509(7500), 282–283. https://www.nature.com/articles/509282a

    [2] Viña, J., & Sastre, J. (2010). Sex differences in longevity. FEBS Letters, 584(16), 3123–3127. https://pubmed.ncbi.nlm.nih.gov/20493817/

    [3] Austad, S. N., & Fischer, K. E. (2016). Sex differences in lifespan. Cell Metabolism, 23(6), 1022–1033. https://www.cell.com/cell-metabolism/fulltext/S1550-4131(16)30202-630202-6)

    [4] National Institutes of Health. (2016). Consideration of Sex as a Biological Variable in NIH-funded Research*. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-102.html